arrow
Z

Zheng-Yi Zhou

analysis group inc
H指数:21
被引数:1,743

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative economic analysis of B-cell maturation antigen-targeted bispecific antibodies in triple-class exposed relapsed/refractory multiple myeloma: linvoseltamab versus teclistamab and elranatamab

三药联合方案暴露后的复发/难治性多发性骨髓瘤中B细胞成熟抗原靶向双特异性抗体的比较经济分析:linvoseltamab与teclistamab和elranatamab的比较

2026-05-010
OAAI
Berotralstat and Health-Related Quality of Life in Hereditary Angioedema: Pooled Analysis of the APeX-2 and APeX-J Trials

伯罗特拉斯特及其对遗传性血管性水肿患者健康相关生活质量的影响:APeX-2和APeX-J试验的合并分析

2026-04-260
OAAI
High-quality genome and transcriptome analyses uncover LEAFY (CpLFY)–mediated regulation of annual harvest and floral organ enhancement in wintersweet (Chimonanthus praecox)

高质量基因组与转录组分析揭示了LEAFY (CpLFY)介导的一年一收和花器官改良在腊梅(Chimonanthus praecox)中的调控机制

2025-11-240
PRE
A Nomogram Integrating M2 Macrophages and Extracellular Matrix Components Outperforms TNM Classification in Pulmonary Sarcomatoid Carcinoma Prognosis: a two-center retrospective study

一种整合M2型巨噬细胞和细胞外基质成分的列线图在肺肉瘤样癌预后预测中优于TNM分类:一项两中心回顾性研究

2025-08-050
PRE
Indirect Comparison of Linvoseltamab vs Teclistamab for the Treatment of Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

三药耐药复发/难治性多发性骨髓瘤治疗中,林洛塞坦单抗与替西利单抗的间接比较

2025-06-220
PREAI
The humanistic burden of focal segmental glomerulosclerosis on patients and care-partners in the United States
2025-04-010
OAAI
Updated efficacy results of olverembatinib (HQP1351) in patients with succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) and potential mechanisms of action (MOA)

奥勒美巴替尼(HQP1351)在琥珀酸脱氢酶(SDH)缺陷型胃肠道间质瘤(GIST)患者中的更新疗效结果及其潜在的作用机制(MOA)

2024-09-011
PRE